Abstract | PURPOSE: PATIENTS AND METHODS: RESULTS: CONCLUSION:
|
Authors | J D Hainsworth, N Levitan, G L Wampler, C P Belani, M S Seyedsadr, J Randolph, L P Schacter, F A Greco |
Journal | Journal of clinical oncology : official journal of the American Society of Clinical Oncology
(J Clin Oncol)
Vol. 13
Issue 6
Pg. 1436-42
(Jun 1995)
ISSN: 0732-183X [Print] United States |
PMID | 7751890
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Organophosphorus Compounds
- etoposide phosphate
- Etoposide
- Cisplatin
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Carcinoma, Small Cell
(drug therapy, mortality)
- Cisplatin
(administration & dosage, adverse effects)
- Etoposide
(administration & dosage, adverse effects, analogs & derivatives)
- Female
- Humans
- Lung Neoplasms
(drug therapy, mortality)
- Male
- Middle Aged
- Organophosphorus Compounds
(administration & dosage, adverse effects)
- Survival Analysis
|